Effect of fetal and maternal intravascular antipyrine infusion on maternal plasma prostaglandin concentrations in the pregnant sheep at 104 to 127 days' gestation

G. Pimentel, J. P. Figueroa, M. D. Mitchell, A. Massmann, P. W. Nathanielsz

Research output: Contribution to journalArticle

17 Scopus citations

Abstract

Antipyrine is commonly used to measure umbilical and uterine blood flow in the pregnant sheep. In the present experiment we investigated the effect of antipyrine on prostaglandin metabolism. Four pregnant ewes at 104 to 127 days' gestation were infused with either 1, 4, or 15 mg of antipyrine per minute via the fetal jugular vein. The 15 mg · min-1 dose was also infused into the maternal jugular vein in a fourth experiment. Prostaglandins in the uterine vein draining the pregnant horn were measured by radioimmunoassay and antipyrine by high-performance liquid chromatography. No change in the concentrations of either 13,14-dihydro-15-keto-prostaglandin F or 6-keto-prostaglandin F was observed with infusion of antipyrine at 1 mg · min-1. The 4 and 15 mg · min-1 infusion rates into the fetal jugular vein induced a significant decrease (p < 0.05) in maternal uterine vein 13,14-dihydro-15-keto-prostaglandin F plasma concentrations. These concentrations decreased from 669.3± 161.3 pg · ml-1 (mean ± SD) before infusion to 306.5 ± 104.0 pg · ml-1 after 3 hours of infusion at 4 mg · min-1 and from 744.2 ± 256.8 to 105.0 ± 24.2 pg · ml-1 at 15 mg · min-1. Significant changes in maternal uterine vein plasma 6-keto-prostaglandin F and the 6-keto-prostaglandin F/13,14-dihydro-15-keto-prostaglandin F ratio occurred only at the 15 mg · min-1 infusion of antipyrine into the fetal jugular vein (p < 0.05). Maternal uterine vein 6-keto-prostaglandin F fell from 86.0 ± 31.6 to 37.0 ± 11.5 pg · ml-1 and the 6-keto-prostaglandin F/13,14-dihydro-15-keto-prostaglandin F ratio rose from 0.14 ± 0.10 to 0.35 ± 0.10. We conclude that: (1) antipyrine at doses currently used to measure uterine and umbilical blood flows inhibits 13,14-dihydro-15-keto-prostaglandin F production and (2) infusion rates of antipyrine less than 1 mg · min-1 probably do not affect maternal prostaglandin metabolism. We therefore recommend that if this method is to be used for measuring blood flow, antipyrine infusion rates should be less than 1 mg · min-1.

Original languageEnglish (US)
Pages (from-to)1181-1185
Number of pages5
JournalAmerican Journal of Obstetrics and Gynecology
Volume155
Issue number6
DOIs
StatePublished - Dec 1986
Externally publishedYes

Keywords

  • Antipyrine
  • prostaglandin
  • umbilical blood flow
  • uterine blood flow

ASJC Scopus subject areas

  • Obstetrics and Gynecology

Fingerprint Dive into the research topics of 'Effect of fetal and maternal intravascular antipyrine infusion on maternal plasma prostaglandin concentrations in the pregnant sheep at 104 to 127 days' gestation'. Together they form a unique fingerprint.

Cite this